CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-02 | Romano Gary Chief Medical Officer | Sale | −2,617 | $6.90 | $18K | 102,120 |
| 2023-06-02 | Rosenthal Arnon Chief Executive Officer | Sale | −5,255 | $6.90 | $36K | 1,651,095 |
| 2023-03-17 | Rosenthal Arnon Chief Executive Officer | Sale | −15,186 | $6.22 | $94K | 1,656,350 |
| 2023-03-03 | Rosenthal Arnon Chief Executive Officer | Grant or award | +42,990 | 1,671,536 | ||
| 2023-03-02 | Romano Gary Chief Medical Officer | Sale | −3,238 | $8.32 | $27K | 104,737 |
| 2023-03-02 | Kenkare-Mitra Sara President and Head of R&D | Sale | −10,124 | $8.32 | $84K | 188,241 |
| 2023-03-02 | GRASSO MARC Chief Financial Officer | Sale | −1,291 | $8.32 | $11K | 34,411 |
| 2023-03-02 | Rosenthal Arnon Chief Executive Officer | Sale | −5,849 | $8.32 | $49K | 1,628,546 |
| 2022-12-02 | Romano Gary Chief Medical Officer | Sale | −2,145 | $8.71 | $19K | 107,975 |
| 2022-11-16 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Other disposition | −500,000 | 11,853,817 | ||
| 2022-11-16 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Other acquisition | +98,533 | 98,533 | ||
| 2022-11-16 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Other disposition | −98,533 | 0 | ||
| 2022-11-16 | MCGUIRE TERRANCE Director | Other disposition | −500,000 | 11,853,817 | ||
| 2022-11-16 | MCGUIRE TERRANCE Director | Other acquisition | +6,429 | 22,317 | ||
| 2022-11-16 | MCGUIRE TERRANCE Director | Other acquisition | +98,533 | 98,553 | ||
| 2022-11-16 | MCGUIRE TERRANCE Director | Other disposition | −98,533 | 0 | ||
| 2022-11-16 | MCGUIRE TERRANCE Director | Other acquisition | +13,133 | 26,266 | ||
| 2022-10-01 | GRASSO MARC Chief Financial Officer | Grant or award | +35,702 | 35,702 | ||
| 2022-10-01 | GRASSO MARC Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +23,801 | 23,801 | ||
| 2022-10-01 | Romano Gary Chief Medical Officer | Grant or award | +20,047 | 110,120 |
Page 11 of 23 · 454 trades